StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Mizuho Securities Downgrades Allergen (AGN) to Neutral Following AbbVie Acquisition
June 26, 2019 4:31 AM
Mizuho Securities analyst Irina Koffler downgraded Allergen (NYSE: AGN) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Downgrades
Next Articles
Wolfe Research Upgrades Abbvie (ABBV) to Peerperform on Valuation
June 27, 2019 9:30 AM